When mouse tissues are probed with murine monoclonal antibodies (MAb) by indirect immunohistochemistry, the secondary antibody detects tissue-bound MAb and irrelevant, endogenous mouse immunoglobulins. The latter are a source of confounding background, especially in diseased tissues. To circumvent this problem, we generated complexes of primary MAb and biotinylated secondary antibodies in vitro for use as antigen-specific probes. After blocking free binding sites in the complexed secondary antibodies with normal mouse serum, the complexes were applied to mouse tissue sections and tissue-bound complexes were visualized with an avidin-biotin detection system. Complexes formed ' Supported by grants CA36245 and NS22475. with 12 different rat or mouse MAb were used to probe sections of normal mice, tumor-bearing transgenic mice, and mice with tumor xenografts. The staining patterns produced by these probes reflected the specificity of the MAb in the complexes, and the labeling of irrelevant, endogenous mouse immunoglobulins was reduced substantially. This novel, indirect immunohistochemical method can be exploited to study normal and diseased mouse tissues using a variety of murine MAb. (JHistochem Cytochem 40:1319-1328,1992) 
Introduction
In indirect enzyme-linked immunohistochemical procedures, the secondary antibody serves the pivotal role of linking the primary antibody bound to the antigen of interest in a tissue section with a tertiary complex containing an enzyme reporter molecule. Two of the most commonly applied methods are the peroxidase-antiperoxidase (PAP) (23) and the avidin-biotin complex (ABC) method (1 1) . In the latter method, biotinylated secondary antibodies are applied to tissue sections to link peroxidase-labeled avidin-biotin complexes with primary antibodies bound to a specific antigen in situ. Simplicity, high signal amplification, and low background are features of the ABC method that have prompted its widespread use as an immunohistochemical detection system.
In the PAP, ABC, and other indirect immunohistochemical methods, the secondary antibody used to recognize the primary antibody could bind to endogenous immunoglobulins in murine tissues. This source of nonspecific background can be eliminated from many normal tissues by in vivo perfusion with buffer to wash out the vascular compartment. However, perfusion with buffer may not wash out extravasated immunoglobulins, especially from diseased or lymphoid tissues. Therefore, it would be attractive to devise an immunohistochemical method that obviates the need to eliminate endogenous immunoglobulins. This would greatly facilitate efforts to study normal or diseased murine tissues and to characterize transgenic mouse models of a variety of diseases. For example, immunohistochemical studies of tumors and tumor xenografts in nude mice could be conducted using a wide variety of existing mouse monoclonal antibodies (MAb) if background staining due to the presence of endogenous mouse immunoglobulins could be eliminated in tissue sections. Several strategies have been devised to overcome this problem. For example, an acidic potassium permanganate solution (13) has been used to remove immunoglobulins from tissue sections, but this procedure damages tissues and/or the antigens of interest (Fung et al., unpublished observations). Alternatively, it is possible to bi-1320 FUNG, MESSING, LEE, TROJANOWSKI otinylate the MAb of interest and to detect them with a reporter molecule coupled to avidin (1, 9, 12) . However, this strategy is impractical and costly when large panels of MAb are used.
Another potential strategy would be to block access of the antimouse secondary antibodies to the endogenous mouse immunoglobulins by pre-incubating the tissue sections with a low dilution of F(ab) fragments from an irrelevant species that recognize endogenous mouse immunoglobulins (6, 20) , but this approach requires large quantities of expensive F(ab) fragments. A more economic strategy would be to use probes formed from in vitrogenerated complexes of primary antibodies and labeled secondary antibodies that have been blocked with pre-immune serum before application to a tissue section (29). The sensitivity of this strategy could be enhanced by using the ABC method to detect tissue-bound complexes composed of an MAb and a biotinylated secondary antibody (also generated in vitro and blocked with mouse pre-immune serum). In the present study, we describe a new modification of the ABC method using this strategy. We used this method to study diseased and normal mouse tissues with rat and mouse MAb. In our procedure, all the immunoglobulin binding sites in the biotinylated secondary antibody were occupied either by the MAb or by immunoglobulins in normal pre-immune mouse serum.
We evaluated this new modification of the ABC method by using a variety of mouse and rat MAb to probe tissue sections from tumorbearing transgenic mice, normal mouse brains, and nude mouse brains with tumor xenografts. We also evaluated this method with sections of normal human cerebellum. These results were compared with those obtained using a standard ABC method (11) . The modified ABC method was superior to the conventional ABC method because it detected a wide variety of antigens in normal and diseased mouse tissues with rat and mouse MAb and because it substantially reduced staining of the endogenous mouse immunoglobulins present in mouse tissue samples. This method should facilitate immunohistochemical studies of normal, diseased, and transgenic mice.
Materials and Methods

Tissues and Xenograft Processing
Four normal young adult Balblc mice were purchased from Charles River Laboratory (Cambridge, MA). The transgenic mice from Tg(PNMT, SV40E)Bri59 line carrying a human phenylethanolamine N-methyl-transferase SV40 early-region fusion gene have been described earlier (1.8) . Spontaneous bilateral primitive cell tumors resembling retinoblastoma and bilateral pheochromocytomas develop postnatally in these mice. The morphological features and biological properties of these transgenic tumors have been reported previously (1, 8) . Two large retinoblastomas and one pheochromocytoma were chosen for this study.
For tumor transplantation studies, five nude mice (NCrNu homozygous) were purchased from the National Cancer Institute, Frederick Cancer Center (Bethesda, MD). The xenografts were made as described previously (7) . Briefly, about 5 x lo4 D283 MED-NGFR cells were injected sterotaxically into the brains of anesthetized nude mice. As described elsewhere (7, 21) , these cells are a human medulloblastoma cell line. They exhibit an immature neuronal phenotype and they are genetically engineered to express the human nerve growth factor receptor (NGFR). These mice were sacrificed 3 weeks after xenograft injection.
All of the mice were deeply anesthetized by intraperitoneal injection of ketamine (83.3 mglkg) and xylazine (16.6 mglkg) before sacrifice, at which time they were perfused with 30 ml of 0.1 M Eis buffer (Sigma; St Louis, MO) at pH 7.6, followed by 50 ml of 150 mM NaCl in 70% ethanol by a perfusion pump (model BSP; Braintree Scientific, Braintree, MA) set at a rate of 217 mllhr. The brain, both eyes, and both adrenal glands were dissected out and immersed in the same fixative for 24-48 hr at room temperature. They were infiltrated by paraffin in a Shandon Hypercenter (Shandon; Pittsburgh, PA) and embedded in paraffin blocks. To assess the modified ABC method in tissues from other species, samples of normal human post-mortem cerebellum from a 53-year-old neurologically normal subject were immersion-fixed in the same fixative, embedded in the same manner, and used in these studies. The protocols for these studies were approved by the Committee on Studies Involving Human Beings and Animals of the University of Pennsylvania. Paraffin sections were cut 5 pm thick and affixed to poly-L-lysine-coated glass slides by incubating them in an oven at 37'C for 1 hr. These preparations were stored at room temperature for 1-2 weeks before immunohistochemical analysis.
Primary Antibodies
The MAb used here as primary antibodies and the worhng dilutions or concentrations at which they were employed are summarized in Table 1 . All of the primary MAb used in this study were raised in mouse or rat. SY38 (30), an anti-synaptophysin MAb and NR4 ( 5 ) , an MAb raised to the low molecular weight neurofilament (NF) subunit (NFL), were purchased from Boehringer Mannheim (Indianapolis, IN). H014, DP1, RMdO20, RMO55, and RM093 (4,14-16.26.28) recognize defined epitopes in either the medium (NFM) or high molecular weight (NF-H) NF subunits. The phosphorylation state of the NF proteins (i.e., independent; nonphosphorylated +, + +, + + + phosphorylated) containing the epitopes recognized by these MAb have been defined as described by Lee et al. (14) . 2.2B10 (16) is an MAb specific for glial fibrillary acidic protein (GFAP), and the anti-MBP MAb (10) recognizes myelin basic protein (MBP). An MAb, MOC-1 (18.19) . has been shown to recognize a human neuronal cell adhesion molecule (N-CAM). FNP7 is a recently developed MAb raised to a non-phosphorylated synthetic peptide corresponding to the amino acid sequence of rat NF-M EEKGKSPVPKSPVEEKG in Balblc mice (25). This sequence is part of the peripheral domain in rat NF-M. Four of the MAb (DP1, H014, 2.2B10, and anti-MBP) are rat MAb, and the others are mouse MAb.
Antibody Purz$cation, Quantitation, and Isotyping
Ascites fluid containing either FNP7 or RM093 was purified by ammonium sulfate precipitation, followed by DEAE column chromatography (2) and high-performance liquid chromatography (HPLC) (3). Fractions containing the antibody were identified by SDS-PAGE and their specificities against the antigens were determined by immunoblotting. The protein concentrations of different MAb were quantitated with the Coomassie Blue G250 reagent (22) (Pierce; Roddord, E.), with bovine serum albumin (Pierce) as standard.
Isotyping was performed by ELISA with isotype-specific peroxidaselabeled antibodies (Southern Biotechnology; Birmingham, AL).
Mo&$eed ABC Immunohistochemical Staining Method with Antibody Complexes as Antigen Probes
Preparation of Antibody Complexes In Vitro. The principal innovation in this modified ABC method was the preparation of an antigen-specific Abbreviations: ind., phosphorylation-independent epitope; -, + , + + , + + + , poorly, slightly, moderately, and heavily phosphorylated epitope, respectively; NF-L, These MAb recognize human but not mouse antigens. This MAb recognizes mouse but not human antigens. The first number specifies the working dilution of the primary MAb; the second number denotes dilution of the secondary antibody and the peroxidase-labeled strep-Refers to the concentration of these MAb in pg/ml; the second digit refers to the dilution of the secondary antibody and the peroxidase-labeled streptavidin-biotin yRM0254 has equal sensitivity with either method in staining of human tissue but reduced sensitivity in the modified method in staining of mouse tissue sections.
NF-M, and NF-H, low. medium, and high molecular weight NF proteins. respectively; ND. not determined; NA. not applicable.
[avidin-biotin complex. The undiluted stock secondary antibody concentration is 9.5 pglml, and the ABC complex has a concentration of 1 mg/ml. com lex probe composed of antibody complexes, as shown in Figure 1 . These probes were prepared by incubating the primary MAb (i.e., the antigen-specific MAb) and the "linking" or biotinylated secondary antibody with each other in vitro. This incubation step resulted in complexes of MAb with the biotinylated secondary antibodies that recognized both mouse and rat MAb. The process required two incubation steps, both of which led to a progres- sive dilution of the primary and secondary antibodies ( Figure 1 ). For this reason, the dilutions of the primary and secondary antibodies, or the concentration of an MAb in the complexes used as antigen-specific probes in this modified ABC method, refer to those achieved after this two-step process (see Table 1 ). In the first incubation step, a given volume of the MAb was incubated with an equal volume of the diluted stock solution of the biotinylated secondary antibodies (Concentrated Supersensitive Kit, Catalog No. ZPOOO-UM; BioGenex, San Ramon, CA) at 37'C for 1 hr in an Eppendorf tube. As recommended by the vendor, the stock solution of the biotinylated secondary antibody was used in this first step at dilutions that ranged from 1:10 to 1:lOO. The working dilution of the primary antibody and the dilution of the biotinylated secondary antibody are listed in Zble 1. The diluent for the primary antibodies, secondary antibodies, and streptavidin-biotin complex was 1% ktal calf serum (FCS) in 0.1 M Tris buffer, pH 7.6. For quantitative studies ofthe modifed and standard ABC methcds using known concentrations of IgG. two different MAb (i.e., FNP7 and RM093) were purified from mites fluid to yield immunoglobulin concentrations of 798.4 and 296.2 pglml, respectively, as described above. The optimal dilutions of the other antibodies were determined by empirical titration.
The second incubation step in the preparation of the antibody complex probe was designed to block the unoccupied binding sites on the secondary antibodies (Figure 1 ). This step entailed the addition of a given volume of normal mouse serum (Sigma) diluted in 1% FCS in 0.1 M Tris buffer to the solution containing the complexes formed by primary and secondary antibodies. Since preliminary studies indicated that a final dilution of 1:2400 of the normal mouse serum blocked binding of the complex to endogenous mouse immunoglobulin, the amount of mouse serum added was adjusted to achieve this final dilution. This solution was then placed in an incubator for 1 hr at 37°C. then removed and chilled on ice for at -.., 
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least 30 min before being applied to tissue sections (without prior filtration or centrifugation). The incubation steps leading to the generation of the antibody complex probes are summarized below.
Steps in Making the Complexes.
1. Mix 1 volume of primary antibody with 1 volume of biotinylated 2. Incubate the mixture at 37°C for 1 hr. 3. Add 1 volume of diluted pre-immune normal mouse serum to the mixture to achieve a final dilution of 1:2400. Mix thoroughly. 4. Incubate the mixture at 37% for 1 hr.
.
Chill the mixture on ice for at least 30 min before application to tissue sections. secondary antibody.
Imm unostaining with Antibody Co mp Zexes as Antigen -specz@ Probes
The subsequent application of the antibody complexes to tissue sections utilized procedures similar to those required for the standard ABC method (see below). Briefly, the tissue sections were deparaffinized in xylene and rehydrated in graded alcohols. After treatment with 5 % H202 in methanol for 30 min, the slides were washed in running tapwater for 10 min, immersed in 0.1 M Tris buffer at pH 7.6 for 5 min, and then blocked in 5 % non-fat dry milk plus 1% FCS in 0.1 M Tris buffer for 1 hr at room temperature. The tissue sections were then washed in two changes of 0.1 M Tris buffer, 3 min each, and immersed in 2% FCS in 0.1 M Tris buffer (FCS-TRIS) for at least 10 min at 4°C. Each tissue section was overlaid with approximately 90-100 pl of the antibody complex solution and incubated at 4°C in a pre-chilled moist chamber for 12-18 hr. This incubation step was terminated by two 10-min washes in 0.1 M Xis buffer at room temperature. All of the subsequent steps were also performed at room temperature. After a 10-min wash in FCS-TRIS, the sections were covered with horseradish peroxidase (HRP)-labeled sueptavidin-biotin complexes (BioGenex) diluted to the same extent as the secondary antibody, which was within the recommended range of dilution of the vendor (i.e., 1:10 to 1:loO). Excess streptavidin-biotin complexes were washed away after a 30-min incubation by two changes of 0.1 M Tris buffer for 5 min each. The bound HRP was visualized by treating the slides for 10 min with freshly prepared and filtered 0.05 mglml diaminobenzidine tetrahydrochloride (DAB) (Sigma) in 0.1 M Tris buffer containing 0.01% Triton X-100 (Sigma) and 0.01 M imidazole and 0.03% H202 (27). Finally, the slides were counterstained with Gill's hematoxylin, dehydrated, cleared, and coverslipped. Below is a flow sheet comparing the two methods.
Step 1.
2.
3. 
Standard Staining Method
For comparison with the modified ABC procedure, a standard ABC method was used here that was based on the protocol described by Hsu et al. (11) (see above). When the slides were incubated with the streptavidin-biotin complex this and subsequent steps in the standard and modified ABC method were the same. Indeed, at this point, slides probed with the modified or standard ABC method were developed together in the same DAB solutions to visualize bound HRP.
Con tro Zs
The supernatant from the SP2lO-Ag14 mouse myeloma cell line (a nonsecreting cell line) was used as negative control. Positive controls included sections of post-mortem human cerebellum that were fixed and processed like the mouse tissues. These sections were immunostained in parallel with the sections of mouse tissues. Furthermore, two different MAb with different antigen specificities were applied to sections in the same experiment as positive controls for each other, and the modified and standard ABC procedures were conducted in parallel.
Results
Preliminary Optimization Of The Modified ABC Method
The modified ABC method described here was critically dependent on the effective blocking of the unoccupied binding sites in the biotinylated antibody with normal mouse serum after the biotinylated antibody had formed a complex with the primary antibody in vitro. During the initial stages in optimizing this important blocking step, a range of dilutions of the mouse serum (i.e., from 1:40 to 1:9600) was studied, and it was determined that a 1:2400 dilution was most effective in preventing the complexed biotinylated secondary antibody from binding to endogenous mouse immunoglobulins in the tissue sections. This dilution blocked effectively when a range of concentrations of the biotinylated antibody was complexed with a given MAb (dilutions ranging from 1:12 to 1:48; data not shown).
To evaluate the modified method, we used several MAb of different isotypes (IgM, IgGl, IgGza) to stain tissue sections. We also tested this method with antigens located within different compartments of neurons or glia, i.e., cytoplasmic intermediate filaments (e.g., NF proteins and GFAP), cytoplasmic vesicles (i.e., synaptophysin), and plasma membrane (N-CAM). Normal tissue and tissue infiltrated with tumor cells were also used to test this method. The optimal dilutions shown in 'Gable 1 were obtained by empirical titration.
Transgenic Mouse Tumors and Tumor Xenogra3s
Invasive tumors, spontaneous or xenografts, may disrupt capillary structure, leading to edema and accumulation of endogenous immunoglobulin around and within the affected tissues (17, 24) . Therefore, to test the ability of the modified ABC method to abolish the background staining due to endogenous immunoglobulin, we stained sections of tissue infiltrated by tumors with the modified ABC method for comparison with the standard ABC method. Background due to endogenous mouse immunoglobulin was abolished almost completely ( Figures 2B, 2D , 2F, and 2H) with the modified ABC method. This procedure always yielded far less background than the standard ABC method (Figures 2A, 2C, 2E , and 2G). For example, when sections of an ocular transgenic mouse retinoblastoma were stained with both the standard and modified ABC method (Figures 2A-2D) , the latter procedure yielded more distinct signal for NF proteins (using FNP7) than the former method (compare Figures 2A and 2C with Figures 2B and 2D ). Presumably, this was because the complexes used in the modified ABC method were prevented from labeling the extravasated mouse immunoglobulins in these ocular tumors.
A similar reduction in background was achieved with the modified ABC method when it was used to probe an adrenal pheochromocytoma that developed in the same transgenic mouse (compare Figures 2E and 2F) . The NFpositive neoplastic chromaffin cells were more sharply delineated with the modified ABC method. The same was true for the D283 MED-NGFR medulloblastoma cell xenografts stained with H014 in the nude mouse brains (compare Figures 2G and 2H) .
Improved staining results were demonstrated with the modified method when mouse tumor tissues were probed with different MAb (Figure 3 ). Specifically, strong positive staining and minimal background were achieved in the retinoblastoma with RM05 5, sY38, DP1 ( Figures 3A-3C) , RM0254, and RM093 (data not shown). Strong specific staining also was achieved in the pheochromocytoma stained with DP1, SY38 ( Figures 3D and 3E) , RM055, RM0254, and RM093 (data not shown). Tumor cells positive for NR4 were also identified by the modified method in the MED 283-NGFR xenograft in nude mice ( Figure 3F ).
Normal Mouse Cerebellum and Human Cerebelhm
To evaluate further the relative sensitivity of the modified and standard ABC methods, we stained normal mouse cerebellum and normal human cerebellum by both methods using 12 different MAb of diverse isotypes. The optimal staining dilutions of those MAb were used, and the slides were developed in the same DAB solution. The MAb can be separated into two major groups. Group 1 MAb demonstrated equal staining sensitivity with either method. Group 2 MAb demonstrated decreased staining sensitivity when the results obtained by the modified method were compared with those of the standard method (Table 1) .
Of the 10 MAb that recognized mouse antigens, four of them (i.e., DP1, RMd020, FNP7, and SY38) exhibited a sensitivity comparable to that of the standard ABC method ( Figures 4A and 4B ).
Six of them (i.e., RM0254, 2.2B10, NR4, RMO55, RM093, and anti-MBP) showed a slight to moderate decrease in sensitivity when compared with the standard method ( Figures 4C and 4D) .
We also tested the antibodies with human cerebellum. Of the 11 MAb that recognized human antigens, seven of them (i.e., MOC-1, DP1, RMd020, H014, RM0254, FNP7, and SY38) demonstrated sensitivity comparable to that of the standard method (Figures4E and4F). Four ofthem (i.e., 2.2B10, NR4. RMO55, and anti-MBP) showed a slight to moderate decrease in sensitivity when the results obtained by the modified method were compared with those of the standard method ( Figures 4G and 4H) .
This modified ABC method can be used with rat and mouse MAb that have different specificities and isotypes.
Discussion
Using a modified ABC staining technique, we demonstrated a significant reduction in background staining due to endogenous immunoglobulin as well as crisp antigen-specific staining with a variety of mouse and rat MAb. Despite a slightly decreased staining with certain MAb, the modified ABC method produced strong positive antigen-specific staining with all the MAb used here. Since vascular structures may be defective (18) in some tumor tissues, and Lime leaky vessels with structural defects have been demonstrated in brain tissues surrounding tumors (24), endogenous immunoglobulin may accumulate in these areas. This is a source of confounding background staining when conventional indirect immunohistochemical methods are used. Therefore, we anticipate that this modified ABC method will be useful for studies of normal or diseased mouse tissues that would otherwise exhibit high background staining due to endogenous immunoglobulins.
The critical step in this modified ABC method is the use of complexes formed by the primary MAb and a secondary antibody in vitro (Figure 1) . Therefore, the formation of "stainable" molecular complexes by the primary MAb, the secondary antibodies, and the normal mouse immunoglobulin is of paramount importance. Although several different MAb formed complexes that were effective antigen-specific probes, poorly understood factors may hinder the sensitivity of this method. For example, the complexes may cause steric hindrance and make the antibody-antigen binding kinetically unfavorable. In addition, very large coinplexes may not bind w : standard (A,C,E,G) and modified (B,D,F,H) ABC method. A and B were stained with SY38. while C and D were probed with RM093. The results of A and B are the same, but note reduced axonal staining by RM093 with the modified ABC method (arrowhead in D) compared to the standard method (arrowhead in C). E and F were stained with MOC-1, while G and H were stained with anti-MBP The results in E and F are the same, but MBP staining is less intense with the modified ABC method. This is evident in the granular cell layer (arrow in G and H) and near Purkinje cells (arrowhead in G and H). M. molecular layer; G, granular layer; W, white matter. Bars = 10 )rm.
avidly to tissue antigens. Furthermore, some primary MAb may bind weakly to the secondary antibody. In this case, abundant complexes formed by the secondary antibody and the immunoglobulin in the normal mouse serum may develop. Obviously, the latter complexes are not useful antigen-specific probes. Finally, since our understanding of how an antibody interacts with its antigen is still limited (31), it is possible that when the secondary antibody complexes with the primary antibody, conformational changes may occur that modify the interaction of the primary antibody with the antigen.
If a reduction in antigen binding by the primary antibody in a complex results from steric hindrance and inappropriate complex formation, further refinements of the modified ABC method could overcome these limitations. One strategy would be to replace the conventional biotinylated secondary antibody with biotinylated F(ab) fragments that recognize the primary MAb. This would reduce steric hindrance and preclude the formation of complexes composed only of secondary antibodies and normal mouse immunoglobulins.
In conclusion, the modified ABC staining technique reported here represents an economic and convenient way to study normal and diseased mouse tissues with MAb raised in mouse or rat. This method is especially useful when perfusion alone is insufficient to eliminate endogenous immunoglobulins. We anticipate that it will facilitate efforts to use transgenic mice as models of human diseases. 24. 
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